Muhlenkamp & Co. Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 0.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 24,481 shares of the healthcare conglomerate’s stock after purchasing an additional 85 shares during the quarter. UnitedHealth Group comprises 4.3% of Muhlenkamp & Co. Inc.’s portfolio, making the stock its 7th largest position. Muhlenkamp & Co. Inc.’s holdings in UnitedHealth Group were worth $ 12,485,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently made changes to their positions in the company. Leo H. Evart Inc. acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $ 403,000. Psagot Value Holdings Ltd. Israel increased its position in UnitedHealth Group by 43.9% in the 4th quarter. Psagot Value Holdings Ltd. Israel now owns 3,676 shares of the healthcare conglomerate’s stock valued at $ 1,846,000 after acquiring an additional 1,121 shares during the period. First International Bank & Trust acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $ 426,000. Okabena Investment Services Inc. increased its position in shares of UnitedHealth Group by 628.2% during the 4th quarter. Okabena Investment Services Inc. now owns 5,986 shares of the healthcare conglomerate’s stock valued at $ 3,006,000 after purchasing an additional 5,164 shares during the period. Finally, Sheets Smith Investment Management acquired a new position in shares of UnitedHealth Group in the 4th quarter worth $ 2,004,000. Institutional investors and hedge funds own 87.48% of the company stock.
UNH stock opened at $ 452.06 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group Incorporated has a one year low of $ 383.12 and a one year high of $ 553.29. The company has a market capitalization of $ 424.11 billion, a PE ratio of 24.74, a price-to-earnings-growth ratio of 1.42 and a beta of 0.83. The company 50 day moving average price is $ 500.28 and its two-hundred day moving average price is $ 490.61.
UnitedHealth Group (NYSE: UNH – Get Rating) last issued its earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $ 5.40 by $ 0.09. The firm had revenue of $ 80.15 billion for the quarter, compared to analysts’ expectations of $ 78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business’s revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the business earned $ 5.31 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be given a $ 1.65 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $ 1.45. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $ 6.60 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s payout ratio is 36.12%.
A number of equities analysts recently weighed in on the company. Truist Financial lifted their price target on UnitedHealth Group from $ 575.00 to $ 610.00 in a research note on Thursday, April 7th. Morgan Stanley lifted their target price on UnitedHealth Group from $ 570.00 to $ 577.00 and gave the company an “overweight” rating in a research note on Monday, April 18th. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $ 561.00 target price on the stock. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $ 482.00 to $ 549.00 and gave the company a “buy” rating in a report on Monday, April 18th. Finally, Oppenheimer upped their target price on UnitedHealth Group from $ 550.00 to $ 600.00 and gave the stock an “outperform” rating in a research report on Monday, April 18th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $ 555.73.
In other UnitedHealth Group news, Director Richard T. Burke sold 3,000 shares of the company stock in a transaction that occurred on Thursday, March 24th. The stock was sold at an average price of $ 508.80, for a total value of $ 1,526,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the company stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $ 493.25, for a total value of $ 1,233,125.00. Following the sale, the director now directly owns 1,220,000 shares in the company, valued at $ 601,765,000. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,000 shares of company stock valued at $ 6,001,485. Corporate insiders own 0.40% of the company stock.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.